Teva Pharmaceutical Industries
TEVA
$16.93
Share price
0.18%
Change (1 day)
135.14%
Change (1 year)
Categories
Teva Pharmaceutical Industries (TEVA) - P/B ratio
P/B ratio as of June 2024 : 2.54
According to Teva Pharmaceutical Industries's latest financial reports the company has a price-to-book ratio of 2.54.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Teva Pharmaceutical Industries - P/B ratio (from 2001 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | 1.46 | 23.76% |
| 2022-12-31 | 1.18 | 49.93% |
| 2021-12-31 | 0.7858 | -16.53% |
| 2020-12-31 | 0.9414 | 31.42% |
| 2019-12-31 | 0.7163 | -33.31% |
| 2018-12-31 | 1.07 | 4.49% |
| 2017-12-31 | 1.03 | -2.23% |
| 2016-12-31 | 1.05 | -46.82% |
| 2015-12-31 | 1.98 | -4.91% |
| 2014-12-31 | 2.08 | 39.29% |
| 2013-12-31 | 1.49 | 7.19% |
| 2012-12-31 | 1.39 | -12.68% |
| 2011-12-31 | 1.60 | -24.99% |
| 2010-12-31 | 2.13 | -17.67% |
| 2009-12-31 | 2.58 | 11.69% |
| 2008-12-31 | 2.31 | -15.27% |
| 2007-12-31 | 2.73 | 23.77% |
| 2006-12-31 | 2.21 | -52.03% |
| 2005-12-31 | 4.60 | 32.62% |
| 2004-12-31 | 3.47 | -27.44% |
| 2003-12-31 | 4.78 | -12.25% |
| 2002-12-31 | 5.44 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | 5.17 | 103.66% | 🇨🇭 Switzerland |
 Pfizer PFE | 1.73 | -31.97% | 🇺🇸 USA |
 Sanofi SNY | 1.46 | -42.36% | 🇫🇷 France |
 Merck MRK | 7.89 | 210.85% | 🇺🇸 USA |
 AstraZeneca AZN | 6.35 | 150.22% | 🇬🇧 UK |
 GlaxoSmithKline GSK | 5.51 | 117.10% | 🇬🇧 UK |
 Dr. Reddy's RDY | 3.73 | 47.06% | 🇮🇳 India |